Globe Life (NYSE:GL) CEO Sells $9,121,500.00 in Stock

Globe Life Inc. (NYSE:GLGet Free Report) CEO James Matthew Darden sold 50,000 shares of the firm’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $182.43, for a total value of $9,121,500.00. Following the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $10,663,215.93. The trade was a 46.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Globe Life Trading Down 0.1%

NYSE GL opened at $183.81 on Thursday. The firm’s 50-day moving average is $173.21 and its two-hundred day moving average is $155.25. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The stock has a market capitalization of $14.27 billion, a P/E ratio of 12.20 and a beta of 0.48.

Globe Life (NYSE:GLGet Free Report) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.73%. Globe Life’s revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, sell-side analysts anticipate that Globe Life Inc. will post 15.7 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Tudor Investment Corp ET AL purchased a new stake in shares of Globe Life in the third quarter valued at about $7,348,000. Jupiter Asset Management Ltd. purchased a new position in shares of Globe Life during the fourth quarter worth about $2,073,000. Northwestern Mutual Wealth Management Co. increased its position in Globe Life by 34,786.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock valued at $123,345,000 after acquiring an additional 879,391 shares during the period. Vanguard Group Inc. increased its position in Globe Life by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after acquiring an additional 86,349 shares during the period. Finally, Strs Ohio raised its stake in Globe Life by 213.7% during the 4th quarter. Strs Ohio now owns 21,907 shares of the company’s stock valued at $3,064,000 after acquiring an additional 14,924 shares during the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have issued reports on GL. Piper Sandler boosted their target price on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. TD Cowen boosted their price objective on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Wells Fargo & Company increased their target price on Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Finally, JPMorgan Chase & Co. increased their target price on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and a consensus price target of $191.67.

Get Our Latest Research Report on Globe Life

About Globe Life

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Featured Articles

Insider Buying and Selling by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.